Chronic kidney disease: global dimension and perspectives
By V. Jha, G. García-García, K. Iseki, Zuo-fei Li, S. Naicker, Brett W Plattner, R. Saran, A. Wang, Chih-Wei Yang. The Lancet, 2013
3,981 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Nephrology
View Paper: https://www.semanticscholar.org/paper/19f5c03aa8fb7211105f78c1457355079a8cde1e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Nephrology
- A. Levey
- Josef Coresh
- D. Rothenbacher
- Marcello Tonelli
- Harold I. Feldman
- A. Levin
- R. Gansevoort
- Giuseppe Remuzzi
Citations in the corpus
- Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2020, background): “The primary cause of CKD varies by setting, with hypertension and diabetes being the most common causes, 15 whereas factors such as HIV 16 and exposure to toxins or heavy metals 17 have an additional role in developing countries.”
- Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. (2017, background): “In LMIC, people with kidney failure routinely die of uraemia due to lack of access to life-saving dialysis and kidney transplantation.(6,7) Worldwide, only half of those requiring RRT can be treated and estimates of those untreated range from 2.”
- Global, Regional, and National Burden of CKD due to Glomerulonephritis from 1990 to 2019 (2022, neutral): “1 (5) High sociodemographic index 251,616.”
- Smartphone based optical biosensor for the detection of urea in saliva (2018, neutral): “by glomerulonephritis and cardiovascular disease [3,4].”
- Diabetic Kidney Disease: Challenges, Progress, and Possibilities. (2017, neutral): “This dramatic rise is one of the highest observed for all reported chronic diseases (11).”
- A systematic analysis of world-wide population-based data on the global burden of chronic kidney disease in 2010 (2015, methodology): “Diabetes and hypertension are the leading causes of CKD in all high-income countries and many low- and middle-income countries (1).”
- Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. (2015, methodology): “Analyses were performed to determine: (1) whether BP-lowering treatment is associated with lower risks of allcause mortality, macrovascular outcomes, and microvascular outcomes, and the magnitude of any such associations; (2) the associations between BP-lowering treatment and these outcomes stratifi”